Sleep and benzodiazepine receptor sub-types.
CL 218,872, which preferentially binds to benzodiazepine (BZ) type 1 receptors, and flurazepam, which is thought to bind to both types 1 and 2, were given alone and in combination to rats. CL 218,872 had little effect on sleep latency, but significantly increased total sleep time. As expected, flurazepam both shortened sleep latency and prolonged total sleep. Pretreatment with CL 218,872 had no effect on these alterations in sleep induced by flurazepam. The implications for possible significance of sub-typing of BZ receptors are discussed.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D005479:Flurazepam / Q000494:pharmacology; D008297:Male; D011724:Pyridazines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000502:physiology*; D012890:Sleep / Q000187:drug effects* / Q000502:physiology; D012894:Sleep Stages / Q000187:drug effects
D014151:Anti-Anxiety Agents; D011724:Pyridazines; D011963:Receptors, GABA-A; C021604:CL 218872; D005479:Flurazepam